Wall Street Analyst Thinks Viking Stock Could Soar 188%
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
Compare Glide Path and Equal Weight strategies to understand which fits your retirement goals. Learn key differences, risks, and practical steps to apply in your portfolio.
25,895 articlesA wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
Medicare will cover GLP-1 weight-loss drugs for eligible beneficiaries beginning this week, a policy shift that could...
Two pharma giants, two very different growth stories. This guide breaks down why Eli Lilly might be the best growth s...
Two popular bank-focused ETFs offer different paths to tap the U.S. financial sector. This piece breaks down broad ba...
SpaceX’s rapid Nasdaq-100 inclusion could redraw the ETF landscape. This guide explains what changes to expect, how i...
Markets recalibrate after a run by the Magnificent Seven, pushing many to rethink concentration. Three ETFs—RSP, SCHV...
A notable fund boosted its Hexcel stake to roughly 23% of its portfolio after a $7.5 million purchase, sending the st...
A new AP-NORC poll reveals a sharp split between women and men on wage opportunities, signaling persistent pay gaps a...
Three ETFs have stood out in 2026 by delivering positive returns while the S&P 500 retreats. RSP, NLR, and VXUS are t...
Wells Fargo downgrades Nike to Equal Weight, trimming the price target amid GLP-1-driven shifts in consumer wardrobes...
A late-night interview about a political candidate sparked a broader discussion on broadcast rules and money. This ar...
Over the last decade, the iShares S&P 100 ETF led large-cap funds with outsized gains, but 2026’s early volatility hi...